Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Sat Dec 16 14:05:38 GMT 2023
by
admin
on
Sat Dec 16 14:05:38 GMT 2023
|
| Source Materials Class | ORGANISM |
| Source Materials Type | AUTOLOGOUS HUMAN |
| Source Materials State | LIVE |
| Source Materials Parent | |
| Part | BLOOD |
| Fraction Material Type | CELL |
| Fraction Name | T-CELLS |
| Record UNII |
7K2YOJ14X0
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
516115
Created by
admin on Sat Dec 16 14:05:38 GMT 2023 , Edited by admin on Sat Dec 16 14:05:38 GMT 2023
|
||
|
FDA ORPHAN DRUG |
933623
Created by
admin on Sat Dec 16 14:05:38 GMT 2023 , Edited by admin on Sat Dec 16 14:05:38 GMT 2023
|
||
|
FDA ORPHAN DRUG |
644018
Created by
admin on Sat Dec 16 14:05:38 GMT 2023 , Edited by admin on Sat Dec 16 14:05:38 GMT 2023
|
||
|
NCI_THESAURUS |
C129826
Created by
admin on Sat Dec 16 14:05:38 GMT 2023 , Edited by admin on Sat Dec 16 14:05:38 GMT 2023
|
||
|
FDA ORPHAN DRUG |
600517
Created by
admin on Sat Dec 16 14:05:38 GMT 2023 , Edited by admin on Sat Dec 16 14:05:38 GMT 2023
|
||
|
FDA ORPHAN DRUG |
730920
Created by
admin on Sat Dec 16 14:05:38 GMT 2023 , Edited by admin on Sat Dec 16 14:05:38 GMT 2023
|
||
|
FDA ORPHAN DRUG |
933723
Created by
admin on Sat Dec 16 14:05:38 GMT 2023 , Edited by admin on Sat Dec 16 14:05:38 GMT 2023
|
||
|
NCI_THESAURUS |
C28681
Created by
admin on Sat Dec 16 14:05:38 GMT 2023 , Edited by admin on Sat Dec 16 14:05:38 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/18/2099
Created by
admin on Sat Dec 16 14:05:38 GMT 2023 , Edited by admin on Sat Dec 16 14:05:38 GMT 2023
|
||
|
NCI_THESAURUS |
C137999
Created by
admin on Sat Dec 16 14:05:38 GMT 2023 , Edited by admin on Sat Dec 16 14:05:38 GMT 2023
|
||
|
FDA ORPHAN DRUG |
933823
Created by
admin on Sat Dec 16 14:05:38 GMT 2023 , Edited by admin on Sat Dec 16 14:05:38 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2479136
Created by
admin on Sat Dec 16 14:05:38 GMT 2023 , Edited by admin on Sat Dec 16 14:05:38 GMT 2023
|
PRIMARY | |||
|
10805
Created by
admin on Sat Dec 16 14:05:38 GMT 2023 , Edited by admin on Sat Dec 16 14:05:38 GMT 2023
|
PRIMARY | |||
|
7K2YOJ14X0
Created by
admin on Sat Dec 16 14:05:38 GMT 2023 , Edited by admin on Sat Dec 16 14:05:38 GMT 2023
|
PRIMARY | |||
|
7K2YOJ14X0
Created by
admin on Sat Dec 16 14:05:38 GMT 2023 , Edited by admin on Sat Dec 16 14:05:38 GMT 2023
|
PRIMARY | |||
|
EF-26
Created by
admin on Sat Dec 16 14:05:38 GMT 2023 , Edited by admin on Sat Dec 16 14:05:38 GMT 2023
|
PRIMARY | |||
|
C125192
Created by
admin on Sat Dec 16 14:05:38 GMT 2023 , Edited by admin on Sat Dec 16 14:05:38 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| TRANSDUCTION OF EXPRESSION VECTOR | RECEPTOR EXPRESSION | RETROVIRAL TRANSFECTION | LISOCABTAGENE MARALEUCEL LENTIVIRUS VECTOR | TO1TNB1HUL |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| INSERTED GENE EXPRESSION VECTOR | LISOCABTAGENE MARALEUCEL TRANSGENE INSERT | 939TQL8M8R | ||||
| VECTOR EXPRESSED PROTEIN | UNSPECIFIED SUBSTANCE |
1cd64bba
(not in database)
|
||||
| CAR-T RECEPTOR | LISOCABTAGENE MARALEUCEL CAR-T RECEPTOR | E18VZQ3GB1 |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| CD4/CD8 RATIO | IMMUNOLOGICAL |
|